about
Bone conditioned media (BCM) improves osteoblast adhesion and differentiation on collagen barrier membranes.In vitro effects of 0 to 120 Grays of irradiation on bone viability and release of growth factors.In vitro characterization of an osteoinductive biphasic calcium phosphate in combination with recombinant BMP2.In vitro effects of hyaluronic acid on human periodontal ligament cells.Effects of platelet rich plasma (PRP) on human gingival fibroblast, osteoblast and periodontal ligament cell behaviourComparison of Two Porcine Collagen Membranes Combined with rhBMP-2 and rhBMP-9 on Osteoblast Behavior In Vitro.Use of platelet-rich fibrin in regenerative dentistry: a systematic review.In vitro evaluation of an injectable biphasic calcium phosphate (BCP) carrier system combined with recombinant human bone morphogenetic protein (rhBMP)-9.Guided bone regeneration with recombinant human bone morphogenetic protein 9 loaded on either deproteinized bovine bone mineral or a collagen barrier membrane.Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?Combination of Collagen Barrier Membrane with Enamel Matrix Derivative-Liquid Improves Osteoblast Adhesion and Differentiation.Hyaluronic Acid Gel-Based Scaffolds as Potential Carrier for Growth Factors: An In Vitro Bioassay on Its Osteogenic Potential.Osteogain® loaded onto an absorbable collagen sponge induces attachment and osteoblast differentiation of ST2 cells in vitro.An in vitro study of fibrin sealant as a carrier system for recombinant human bone morphogenetic protein (rhBMP)-9 for bone tissue engineering.Effects of air polishing and an amino acid buffered hypochlorite solution to dentin surfaces and periodontal ligament cell survival, attachment, and spreading.Optimized Platelet-Rich Fibrin With the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response.Effect of hyaluronic acid on morphological changes to dentin surfaces and subsequent effect on periodontal ligament cell survival, attachment, and spreading.Osteogenic potential of rhBMP9 combined with a bovine-derived natural bone mineral scaffold compared to rhBMP2.Osteogain improves osteoblast adhesion, proliferation and differentiation on a bovine-derived natural bone mineral.Pre-coating deproteinized bovine bone mineral (DBBM) with bone-conditioned medium (BCM) improves osteoblast migration, adhesion, and differentiation in vitro.Recombinant Human Bone Morphogenetic Protein 9 (rhBMP9) Induced Osteoblastic Behavior on a Collagen Membrane Compared With rhBMP2.Giant cells around bone biomaterials: Osteoclasts or multi-nucleated giant cells?Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review.Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.Erratum to: Effects of platelet rich plasma (PRP) on human gingival fibroblast, osteoblast and periodontal ligament cell behaviour.Growth factor delivery of BMP9 using a novel natural bovine bone graft with integrated atelo-collagen type I: Biosynthesis, characterization, and cell behavior.Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.Effect of Irrigation Time of Antiseptic Solutions on Bone Cell Viability and Growth Factor Release.Superior bone-inducing potential of rhBMP9 compared to rhBMP2.Effect of recombinant human bone morphogenic protein 9 (rhBMP9) loaded onto bone grafts versus barrier membranes on new bone formation in a rabbit calvarial defect model.Recombinant human bone morphogenetic protein (rhBMP)9 induces osteoblast differentiation when combined with demineralized freeze-dried bone allografts (DFDBAs) or biphasic calcium phosphate (BCP).Comparison of three block bone substitutes for bone regeneration: long-term observation in the beagle dog.Comparative release of growth factors from PRP, PRF, and advanced-PRF.Absorbable collagen sponges loaded with recombinant bone morphogenetic protein 9 induces greater osteoblast differentiation when compared to bone morphogenetic protein 2.Fabrication and evaluation of carbonate apatite-coated calcium carbonate bone substitutes for bone tissue engineeringCholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineeringEffects of Antiseptic Solutions Commonly Used in Dentistry on Bone Viability, Bone Morphology, and Release of Growth FactorsHyaluronic acid slows down collagen membrane degradation in uncontrolled diabetic rats
P50
Q36080650-F13B8272-51D0-4C11-82F0-D0D9FC6B4F1DQ36081005-11694641-F356-49EA-B0E3-429E920DACC6Q36093370-9BB39256-C64F-447B-A6BB-552BD0E36DCBQ36250688-A94454FE-2D70-4DD0-AD1A-52961095977EQ36392102-771D8723-8244-46B8-8AA5-724356776FFDQ38657546-4E266A86-191C-4A10-B38B-75810DD2C378Q38678081-411803EC-1CDB-4DBE-8AC0-CEA2F1717B3CQ38681546-EBC33BB5-2090-42C9-9D78-0129041FCEBBQ38688242-46FFAC9A-5121-47A6-8115-43E233BCAD24Q38762385-20CF5016-B472-4546-B306-E375B201630FQ38769517-89DBFD55-7C25-439F-B59B-507D25BB1AE6Q38787340-9D0189A0-F2BE-4402-915D-711180B4B385Q38788257-FC4E44D2-41A6-426F-9A03-A698F30596BEQ38795799-DCA15790-AE08-4F1C-9A45-7898877B2463Q38824174-91B82EF3-1A3C-41EF-819D-F458B8B77ACEQ38825115-6EA1294E-73EC-4A74-9D4F-55EBF2BA4CC8Q38865523-D38C41EC-68FA-41AD-9E7A-2A5D6F1938FDQ38893605-3F66AE57-53C6-4BB6-AD26-F994F1EFEAA2Q38902863-B1B287EC-EE0E-4B82-B577-CBDDF1461880Q38908228-45309AE8-24C7-462C-B66B-3A983FE28544Q38922444-DB430D57-F417-4EAD-8DED-B15375555B0DQ38964191-B7F8ED50-CE33-4179-A655-2146CD6DFD02Q38965537-8CC18084-EEE3-4739-B43B-8CD858140C54Q39036661-59F91EC7-823D-4C50-9DF6-979DB2ED5B75Q42338968-CBFD8495-8496-4E4F-BE90-6A82447ED45BQ45858882-0DF5EC52-AC4E-4B55-B5AB-3DFB2013EFF0Q47235454-3B323B14-1BFE-455F-AA3C-4BF19DA15B46Q47588220-C0F2D90B-C531-4761-B0FE-09CFAC332D94Q48111157-BF169E51-E705-47B3-998B-608690CE2A4AQ48362036-D9B058E5-37A0-43B3-B750-6DD25F22AC48Q50226053-B7E4133B-9FCF-4952-9011-10B66AAD8EF9Q52646900-10770DA6-9C13-4260-9C52-953DD5285C2DQ53199057-AF5D7E95-4AAA-405A-B652-07BB43CB90A7Q54129228-D7D11E05-C519-4DD9-8713-C71EE300F248Q57213174-F4082FC1-B240-4FF7-87DD-5D157E05BC07Q84576833-19F5D550-3B6E-4AA3-B2F6-9773E902B946Q86557145-6A3497B1-A9FE-4694-AAC1-E928CACBE4B1Q92694029-CAA9171C-F97E-48B4-AB42-53CC2A81C38D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Masako Fujioka-Kobayashi
@en
Masako Fujioka-Kobayashi
@nl
type
label
Masako Fujioka-Kobayashi
@en
Masako Fujioka-Kobayashi
@nl
prefLabel
Masako Fujioka-Kobayashi
@en
Masako Fujioka-Kobayashi
@nl
P31
P496
0000-0002-1511-9085